WebApr 6, 2024 · Finch Therapeutics Group (NASDAQ:FNCH) has a market capitalization of $17.96 million and generates $860,000.00 in revenue each year. The company earns $ … WebSOMERVILLE, Mass., March 23, 2024 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome …
First Nations Health Authority - FNHA
WebApr 29, 2024 · Important Dates for Investors in FNCH: -Finch Therapeutics Group Inc is set to release earnings on 5/12/2024. Over the last 12 months, the company has reported EPS of $-1.94. -We do not have a set dividend date for Finch Therapeutics Group Inc at this time. Click Here To Get The Full Report on Finch Therapeutics Group Inc (FNCH) WebMar 19, 2024 · Finch’s shares are expected to begin trading on the Nasdaq Global Select Market on Friday, March 19, 2024 under the ticker symbol “FNCH.” The offering is expected to close on March 23, 2024,... small wood bench for shower
WebFinch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical … WebMar 17, 2024 · Finch Therapeutics Group saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 196,500 shares, an increase of 10.1% from the previous total of 178,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. WebApr 29, 2024 · The clinical-stage biotech Finch Therapeutics ( NASDAQ: FNCH) announced that the U.S. Food and Drug Administration (FDA) lifted the clinical hold on its investigational new drug (IND) application... hikvision contact south africa